NCT05568602View on ClinicalTrials.gov

Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal Failure

CompletedOBSERVATIONAL

Enrollment

1,034

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 1, 2021

Study Completion Date

August 1, 2021

Conditions

Cushing Syndrome

Interventions

DIAGNOSTIC_TEST

Dexamethasone suppression test

1 mg Dexamethasone overnight suppression test for screening of hypercortisolism

Trial Locations (1)

34899

Özlem ÜSTAY, Istanbul

Sponsors

Lead Sponsor

Marmara University

All Listed Sponsors

lead

Marmara University

OTHER

NCT05568602 - Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal Failure | Biotech Hunter | Biotech Hunter